COMMUNIQUÉS West-GlobeNewswire
-
New LogicMark Survey Reveals Safety Concerns of Gen Z Women & Workarounds They've Adapted
18/08/2026 -
Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors
18/08/2026 -
BioPorto activates the first US clinical site as part of the ProNephro AKI® U.S. Adult Urine NGAL Validation Study.
18/08/2026 -
Akari Therapeutics Builds Momentum for AKTX-101 with Compelling Urothelial Cancer Data Supporting Differentiated ADC Strategy
18/08/2026 -
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
18/08/2026 -
FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
18/08/2026 -
Direct Meds Updates DirectMax Clinical Review and Licensed-Pharmacy Fulfillment Details (2026)
18/08/2026 -
Jabra Enhance introduces a new lineup of FDA-cleared self-fitting hearing aids, 3 new models with improved hearing technology and in-app self-tuning
18/08/2026 -
NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t
18/08/2026 -
Trethera Appoints World-Renowned ALS Researcher Dr. Merit Cudkowicz to Scientific Advisory Board
18/08/2026 -
USAHS Celebrates 20,000 Degrees Amid Continued Growth and Program Expansion
18/08/2026 -
Ketogenic Foundation Announces 2026 Conference Exploring the Future of Metabolic Health and Chronic Disease Care
18/08/2026 -
U.S. Oral Surgery Management Partners with Cottonwood Oral & Maxillofacial Surgery of Albuquerque
18/08/2026 -
SK pharmteco Marks Construction Progress with Ribbon Cutting for Two Advanced Manufacturing Facilities at Swords, Ireland Campus
18/08/2026 -
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
18/08/2026 -
Polomar Health Services Reports Second-Quarter Revenue of $1.53 Million and Positive Net Income
18/08/2026 -
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
18/08/2026 -
Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
18/08/2026 -
Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India’s Nuclear Regulatory Authority for International Manufacturing Center
18/08/2026
Pages